DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $43,039 | +2.7% | 173,470 | -0.7% | 0.16% | +9.6% |
| Q2 2023 | $41,924 | -5.1% | 174,681 | -0.4% | 0.15% | -18.9% |
| Q1 2023 | $44,188 | -4.8% | 175,321 | +0.3% | 0.18% | -0.6% |
| Q4 2022 | $46,407 | -99.9% | 174,843 | -2.5% | 0.18% | -8.6% |
| Q3 2022 | $46,310,000 | +2.2% | 179,296 | -0.2% | 0.20% | -3.4% |
| Q2 2022 | $45,306,000 | -24.5% | 179,651 | -12.2% | 0.20% | -20.2% |
| Q1 2022 | $60,023,000 | -15.7% | 204,625 | -5.4% | 0.26% | -6.9% |
| Q4 2021 | $71,187,000 | +24.1% | 216,367 | +14.8% | 0.28% | +12.7% |
| Q3 2021 | $57,371,000 | +20.4% | 188,446 | +6.1% | 0.24% | +16.7% |
| Q2 2021 | $47,651,000 | +21.8% | 177,562 | +2.1% | 0.21% | +10.5% |
| Q1 2021 | $39,127,000 | +10.0% | 173,838 | +8.6% | 0.19% | +10.5% |
| Q4 2020 | $35,566,000 | +10.6% | 160,106 | +7.3% | 0.17% | -6.0% |
| Q3 2020 | $32,143,000 | +24.7% | 149,272 | +2.4% | 0.18% | +12.3% |
| Q2 2020 | $25,767,000 | +35.2% | 145,714 | +5.8% | 0.16% | +7.9% |
| Q1 2020 | $19,060,000 | -7.1% | 137,707 | +3.0% | 0.15% | +11.9% |
| Q4 2019 | $20,513,000 | +10.2% | 133,653 | +3.7% | 0.14% | 0.0% |
| Q3 2019 | $18,607,000 | +5.3% | 128,828 | +4.2% | 0.14% | -0.7% |
| Q2 2019 | $17,671,000 | +6.4% | 123,641 | -1.7% | 0.14% | -0.7% |
| Q1 2019 | $16,602,000 | +23.7% | 125,754 | -3.4% | 0.14% | +6.2% |
| Q4 2018 | $13,419,000 | +4.2% | 130,132 | +9.8% | 0.13% | +16.2% |
| Q3 2018 | $12,875,000 | +16.9% | 118,488 | +6.2% | 0.11% | +4.7% |
| Q2 2018 | $11,012,000 | +4.3% | 111,591 | +3.5% | 0.11% | 0.0% |
| Q1 2018 | $10,558,000 | +6.9% | 107,836 | +1.4% | 0.11% | +2.9% |
| Q4 2017 | $9,874,000 | +8.1% | 106,378 | -0.1% | 0.10% | -1.0% |
| Q3 2017 | $9,133,000 | -3.9% | 106,469 | -5.5% | 0.10% | -12.6% |
| Q2 2017 | $9,505,000 | +6.2% | 112,633 | +7.6% | 0.12% | 0.0% |
| Q1 2017 | $8,949,000 | +12.8% | 104,635 | +2.6% | 0.12% | -0.8% |
| Q4 2016 | $7,936,000 | +9.3% | 101,954 | +10.0% | 0.12% | -6.2% |
| Q3 2016 | $7,263,000 | -49.0% | 92,648 | -34.2% | 0.13% | -55.9% |
| Q2 2016 | $14,228,000 | +127.3% | 140,878 | +113.5% | 0.29% | +76.8% |
| Q1 2016 | $6,260,000 | +2.3% | 65,995 | +0.2% | 0.16% | +3.8% |
| Q4 2015 | $6,119,000 | +9.6% | 65,876 | +0.5% | 0.16% | 0.0% |
| Q3 2015 | $5,584,000 | -99.9% | 65,528 | +2.0% | 0.16% | +37.4% |
| Q2 2015 | $5,501,012,000 | +87747.5% | 64,272 | -12.9% | 0.12% | -1.7% |
| Q1 2015 | $6,262,000 | -99.9% | 73,754 | +3.7% | 0.12% | -4.1% |
| Q4 2014 | $6,094,578,000 | +28.8% | 71,107 | +14.2% | 0.12% | +24.5% |
| Q3 2014 | $4,730,552,000 | +37.4% | 62,260 | +42.4% | 0.10% | +30.7% |
| Q2 2014 | $3,442,814,000 | -1.9% | 43,729 | -6.6% | 0.08% | -11.8% |
| Q1 2014 | $3,510,642,000 | +11.5% | 46,809 | +14.8% | 0.08% | +2.4% |
| Q4 2013 | $3,149,179,000 | +17.7% | 40,792 | +5.7% | 0.08% | +3.8% |
| Q3 2013 | $2,675,431,000 | +24.9% | 38,595 | +14.0% | 0.08% | -64.3% |
| Q2 2013 | $2,142,786,000 | – | 33,851 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |